SEMA4D and atherosclerosis: The extracellular domain of CD100 retained biological activity after shedding from immune cell surface upon activation, resulting in the alteration of macrophage differentiation and phenotype in atherosclerosis [13] and facilitation of CD8+ T cells activity in chronic hepatitis [14, 33].